share_log

Eli Lilly and Co | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jan 4 13:00
Summary by Futu AI
LILLY ENDOWMENT INC, a major stockholder with over 10% stake in Eli Lilly and Co, is set to sell 225,000 shares of common stock on 01/04/2024. The shares, originally acquired as a gift from the J.K. Lilly Sr. Trust on 02/10/1948, have an aggregate market value of approximately $138,982,500. This transaction follows a recent sale of 215,000 shares in the past three months, which grossed $130,169,858. The upcoming sale continues the Endowment's pattern of divesting shares in the pharmaceutical giant, although the number of shares held by LILLY ENDOWMENT INC after the transaction was not disclosed.
LILLY ENDOWMENT INC, a major stockholder with over 10% stake in Eli Lilly and Co, is set to sell 225,000 shares of common stock on 01/04/2024. The shares, originally acquired as a gift from the J.K. Lilly Sr. Trust on 02/10/1948, have an aggregate market value of approximately $138,982,500. This transaction follows a recent sale of 215,000 shares in the past three months, which grossed $130,169,858. The upcoming sale continues the Endowment's pattern of divesting shares in the pharmaceutical giant, although the number of shares held by LILLY ENDOWMENT INC after the transaction was not disclosed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.